HRK
(Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain) (HRK))
蛋白结构域
N-Term
宿主
人
资源
合成
应用范围
Blocking Peptide (BP), Western Blotting (WB)
产品特性
This is a synthetic peptide designed for use in combination with anti-HRK antibody (Catalog #: ARP46364_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
限制
仅限研究用
状态
Lyophilized
溶解方式
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
浓度
1 mg/mL
缓冲液
Final peptide concentration is 1 mg/mL in PBS.
注意事项
Avoid repeated freeze-thaw cycles.
储存条件
-20 °C
储存方法
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
抗原
HRK
(Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain) (HRK))
别名
DP5 Peptide, HARAKIRI Peptide, AI838259 Peptide, Bid3 Peptide, harakiri Peptide, Dp5 Peptide, harakiri, BCL2 interacting protein Peptide, harakiri, BCL2 interacting protein (contains only BH3 domain) Peptide, HRK Peptide, Hrk Peptide
背景
Activator of apoptosis Hrk regulates apoptosis through interaction with death-repressor proteins Bcl-2 and Bcl-X(L). The HRK protein lacks significant homology to other BCL2 family members except for an 8-amino acid region that was similar to the BCL2 hom
Alias Symbols: DP5, HARAKIRI
Protein Interaction Partner: BCL2,BCL2,BCL2A1,BCL2L1,BCL2L1,BCL2L1,BCL2L2,BNC1,BAD,BCL2,BCL2A1,BCL2L1,BCL2L2,C1QBP,BCL2,BCL2A1,BCL2L1,BCL2L2,MCL1